Profound Medical (TSE:PRN) has released an update. Profound Medical Corp., known for its innovative, incision-free medical therapies, is set to ...
A 40-year-old Human Resources Manager, Bisi, with uterine fibroids, delayed her treatment for over four years for fear of ...
Axicabtagene ciloleucel, known by the brand name Yescarta, has been accepted for treating adults with two types of blood cancer.
Theramex has announced that the Scottish Medicine Consortium (SMC) has recommended Yselty® for the treatment of moderate to severe symptoms of uterine fibroids (UFs) aligned to the product indication ...
Theramex has announced that the Scottish Medicine Consortium (SMC) has recommended Yselty® for the treatment of moderate to severe symptoms of uterine fibroids (UFs) aligned to the product indication ...
The author describes the hurdles with medtech innovation driven by homogenous groups and some practical strategies for the ...
Although hysterectomy remains the most common procedure for treating fibroids and fibroids are the leading indication for ...
The presence of fibroids made it difficult for her ovaries to be seen and accessed for egg retrieval, resulting in fewer eggs ...
Zacks.com on MSN6d
Hologic Post Q4 Earnings Miss: Time to Buy, Hold or Sell the Stock?On Monday, Hologic HOLX released its fiscal 2024 fourth-quarter financial report after the closing bell, with revenues slightly surpassing the consensus mark. The bottom line fell short of estimates ...
Noncancerous uterine growths disproportionately impact Black women, fibroids can lead to a variety of symptoms. From heavy ...
Uterine fibroids are the major reason for the removal of the uterus by hysterectomy. However, researchers recommend minimally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback